Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
Recruiting · NCT07436312 · Interventional (participants receive a specific treatment) · Lead sponsor: Gustave Roussy, Cancer Campus, Grand Paris
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The U-TRANS study was initiated by Gustave Roussy, which is its sponsor\*. It is part of the Interception Program and aims to reduce the consumption of ultra-processed foods in order to improve the overall quality of the diet among people at high risk of cancer (WCRF score ≤ 5, corresponding to low adherence to nutritional cancer prevention recommendations: eating a diet rich in whole grains, vegetables, fruit and fibre, and limiting ultra-processed foods, red meat, processed meats, sugary drinks and alcohol). It assesses the impact of a digital intervention (based on the use of the Open Food Facts app) as a complement to the nutritional education provided by the Interception program.
Who can take part
Inclusion criteria
- Age \> 18 years,
- Individuals at increased risk of different cancers as defined within the Interception program,
- With a baseline WCRF score ≤ 5 at entry in the Interception program,
- Agreeing to participate and who have given their written agreement for the study,
- Agreeing to fill in the questionnaires on the dedicated platform for the duration of the study,
- Participant have and accept to use their smartphone,
- All participants must understand spoken and written French language
Exclusion criteria
- Psychiatric disorders or cognitive impairments precluding participation,
- Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent.
Where it is running
3 locations listed.
- Institut Sainte Catherine - Avignon, France
- Eugène Marquis - Rennes, France
- Gustave Roussy - Villejuif, France